Wang LG et al. |
Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line. |
2004 |
Oncogene |
pmid:15156193
|
Yokota T et al. |
Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. |
2004 |
Oncogene |
pmid:15107822
|
Suzuki M et al. |
Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b. |
2006 |
Oncogene |
pmid:16331260
|
McGarry LC et al. |
Invasion of v-Fos(FBR)-transformed cells is dependent upon histone deacetylase activity and suppression of histone deacetylase regulated genes. |
2004 |
Oncogene |
pmid:15107823
|
Guo WH et al. |
Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. |
2002 |
Oncogene |
pmid:12447699
|
Ong DC et al. |
LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer. |
2009 |
Oncogene |
pmid:19734946
|
Tessema M et al. |
Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis. |
2010 |
Oncogene |
pmid:20562917
|
Vincent A et al. |
Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. |
2007 |
Oncogene |
pmid:17471237
|
Augenlicht L et al. |
Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturation. |
2003 |
Oncogene |
pmid:12902981
|
Zhong S et al. |
Phosphorylation at serine 28 and acetylation at lysine 9 of histone H3 induced by trichostatin A. |
2003 |
Oncogene |
pmid:12917630
|
Quan H et al. |
Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition. |
2014 |
Oncogene |
pmid:23770846
|
Wu Y et al. |
Negative regulation of bcl-2 expression by p53 in hematopoietic cells. |
2001 |
Oncogene |
pmid:11313951
|
Mühlisch J et al. |
Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood. |
2006 |
Oncogene |
pmid:16186793
|
Cismasiu VB et al. |
BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter. |
2005 |
Oncogene |
pmid:16091750
|
Cras A et al. |
Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells. |
2007 |
Oncogene |
pmid:17213810
|
Karagiannis TC et al. |
Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments. |
2007 |
Oncogene |
pmid:17213813
|
Toyooka S et al. |
Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells. |
2002 |
Oncogene |
pmid:12082623
|
Sengupta S et al. |
Tumor suppressor p53 represses transcription of RECQ4 helicase. |
2005 |
Oncogene |
pmid:15674334
|
Busson M et al. |
Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation. |
2005 |
Oncogene |
pmid:15674337
|
López-Soto A et al. |
HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer. |
2009 |
Oncogene |
pmid:19430493
|
Sengupta S et al. |
Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1. |
2011 |
Oncogene |
pmid:20856196
|
Shin HJ et al. |
Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation. |
2003 |
Oncogene |
pmid:12813458
|
Chan AS et al. |
Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. |
2003 |
Oncogene |
pmid:14534543
|
Krishnan M et al. |
HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability. |
2010 |
Oncogene |
pmid:19881542
|
Shteper PJ et al. |
Role of promoter methylation in regulation of the mammalian heparanase gene. |
2003 |
Oncogene |
pmid:14586400
|
Hirose T et al. |
p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. |
2003 |
Oncogene |
pmid:14586402
|
Ibanez de Caceres I et al. |
IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer. |
2010 |
Oncogene |
pmid:20023704
|
Zubia A et al. |
Identification of (1H)-pyrroles as histone deacetylase inhibitors with antitumoral activity. |
2009 |
Oncogene |
pmid:19169274
|
Kumar KS et al. |
Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells. |
2006 |
Oncol. Rep. |
pmid:17016591
|
Kang FW et al. |
Effects of trichostatin A on HIF-1α and VEGF expression in human tongue squamous cell carcinoma cells in vitro. |
2012 |
Oncol. Rep. |
pmid:22552321
|
Meng J et al. |
The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways. |
2012 |
Oncol. Rep. |
pmid:22552631
|
Kim SH et al. |
Regulation of the HIF-1alpha stability by histone deacetylases. |
2007 |
Oncol. Rep. |
pmid:17273746
|
Anh TD et al. |
The histone deacetylase inhibitor, Trichostatin A, induces G2/M phase arrest and apoptosis in YD-10B oral squamous carcinoma cells. |
2012 |
Oncol. Rep. |
pmid:21993600
|
Ganslmayer M et al. |
A quadruple therapy synergistically blocks proliferation and promotes apoptosis of hepatoma cells. |
2004 |
Oncol. Rep. |
pmid:15069530
|
Ma X et al. |
Effect of LIV1 on the sensitivity of ovarian cancer cells to trichostatin A. |
2015 |
Oncol. Rep. |
pmid:25420545
|
Wang B et al. |
Reversion of trichostatin A resistance via inhibition of the Wnt signaling pathway in human pancreatic cancer cells. |
2014 |
Oncol. Rep. |
pmid:25224651
|
Wang JH et al. |
HDAC inhibitors, trichostatin A and valproic acid, increase E‑cadherin and vimentin expression but inhibit migration and invasion of cholangiocarcinoma cells. |
2018 |
Oncol. Rep. |
pmid:29767267
|
Zhang X et al. |
Tyrphostin B42 attenuates trichostatin A-mediated resistance in pancreatic cancer cells by antagonizing IL-6/JAK2/STAT3 signaling. |
2018 |
Oncol. Rep. |
pmid:29393444
|
Ji M et al. |
HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells. |
2015 |
Oncol. Rep. |
pmid:25813246
|
Um SJ et al. |
In vitro antitumor potential of 4-BPRE, a butyryl aminophenyl ester of retinoic acid: role of the butyryl group. |
2004 |
Oncol. Rep. |
pmid:14767528
|
Wu DS et al. |
Epigallocatechin-3-gallate and trichostatin A synergistically inhibit human lymphoma cell proliferation through epigenetic modification of p16INK4a. |
2013 |
Oncol. Rep. |
pmid:24064951
|
Shao G et al. |
Inactivation of EGFR/AKT signaling enhances TSA-induced ovarian cancer cell differentiation. |
2017 |
Oncol. Rep. |
pmid:28393191
|
Nakajima S et al. |
Trichostatin A with adenovirus-mediated p53 gene transfer synergistically induces apoptosis in breast cancer cell line MDA-MB-231. |
2009 |
Oncol. Rep. |
pmid:19513516
|
Yanada M et al. |
Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines. |
2005 |
Oncol. Rep. |
pmid:16142337
|
Zhang NH et al. |
Rejection of adenovirus infection is independent of coxsackie and adenovirus receptor expression in cisplatin-resistant human lung cancer cells. |
2016 |
Oncol. Rep. |
pmid:27373420
|
Kang HR et al. |
Butyrate-mediated acquisition of chemoresistance by human colon cancer cells. |
2016 |
Oncol. Rep. |
pmid:27277338
|
Liu Z et al. |
Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells. |
2008 |
Oncol. Rep. |
pmid:18575731
|
Puppin C et al. |
Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells. |
2011 |
Oncol. Rep. |
pmid:21152868
|
Puppin C et al. |
Histone deacetylase inhibitors induce thymidine phosphorylase expression in cultured breast cancer cell lines. |
2011 |
Oncol. Rep. |
pmid:21617864
|
Meng CF et al. |
Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells. |
2009 |
Oncol. Rep. |
pmid:19787243
|